State and federal Oklahoma lawmakers say they plan to prioritize enforcement actions on pharmacy benefit managers, the ...
A conservative group led by Mike Pence allies opposes Trump's Most-Favored-Nation drug pricing agreements with Eli Lilly and ...
As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...
The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that’s not necessarily what you pay.
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
Facing mounting financial pressures, insurance companies are changing the prescription drug coverage available to many ...
With pricing pressures climbing, Pfizer, Eli Lilly and other major drugmakers are looking to sell their products directly to ...
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
The U.S. Food and Drug Administration (FDA) classified the recall as a Class II risk. This indicates that using the product ...